Sanofi (France)
NEWS
Similar to the Biotech Bay list, BioSpace takes a look at the top 10 2019 Life Sciences Ideal Employer Report’s for Genetown.
Sanofi announced it is acquiring Synthorx for $68 per share in cash, a value of $2.5 billion. The deal has been unanimously approved by both companies’ boards.
According to PhRMA, there are 264 vaccines in development to prevent and treat diseases. These include infectious diseases (137), cancer (101), allergies (10), autoimmune disease (8) and Alzheimer’s disease (4).
Previously, Toujeo was approved only for adults aged 18 years and older.
The company’s consumer health unit is worth about $30 billion.
It was a busy week for clinical trial updates for the first week of November. Here’s a look.
It was the first randomized, controlled trial comparing Toujeo to Gla-100 in this patient population.
The digital-enabled aspect of the manufacturing plant is designed to leverage better use of data to optimize manufacturing processes and increase efficiencies.
GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
JOBS
IN THE PRESS